CIK 0000908259 · Non-accelerated filer<br>Smaller reporting company
Oncotelic Therapeutics, Inc.
Sign in to watch- Ticker
- OTLC
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 133679168
- Phone
- 650-635-7000
- Business address
- 29397 AGOURA RD., #107, AGUORA HILLS, CA, 91301
- Former names
- MATEON THERAPEUTICS INC, OXIGENE INC
- Open-market buys, last 90 days
- $23,537
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$23,537. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-03-21 | LOAR MATTHEW M Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +262,500 | 262,500 | ||
| 2016-03-21 | Pedder Simon Director | Grant or award · Stock Option (Right to Buy) | +99,711 | 99,711 | ||
| 2015-07-20 | LOAR MATTHEW M Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2015-05-28 | RICHING BARBARA Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2015-05-28 | Schwieterman William D President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2015-05-28 | Schwieterman William D President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2015-05-28 | HOWSON TAMAR D Director | Grant or award · Stock Option (Right to Buy) | +77,996 | 77,996 | ||
| 2015-05-28 | McMahon Gerald PhD Director | Grant or award · Stock Option (Right to Purchase) | +77,996 | 77,996 | ||
| 2015-05-28 | DRISCOLL FREDERICK W Director | Grant or award · Stock Option (Right to Buy) | +77,996 | 77,996 | ||
| 2015-05-28 | CHAPLIN DAVID Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +225,000 | 225,000 | ||
| 2014-07-02 | Schwieterman William D Director | Grant or award · Stock Option (Right to Buy) | +5,280 | 5,280 | ||
| 2014-07-02 | McMahon Gerald PhD Director | Grant or award | +3,847 | 18,611 | ||
| 2014-07-02 | HOWSON TAMAR D Director | Grant or award · Stock Option (Right to Buy) | +5,280 | 5,280 | ||
| 2014-07-02 | DRISCOLL FREDERICK W Director | Grant or award · Stock Option (Right to Buy) | +7,920 | 7,920 | ||
| 2014-05-30 | RICHING BARBARA Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2014-05-15 | CHAPLIN DAVID President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2014-01-02 | McMahon Gerald PhD Director | Grant or award | +3,584 | 14,764 | ||
| 2014-01-02 | Schwieterman William D Director | Grant or award · Stock Option (Right to Buy) | +4,880 | 4,880 | ||
| 2014-01-02 | HOWSON TAMAR D Director | Grant or award · Stock Option (Right to Buy) | +4,880 | 4,880 | ||
| 2014-01-02 | CHAPLIN DAVID Director | Grant or award · Stock Option (Right to Buy) | +4,880 | 4,880 |
Page 6 of 7 · 140 trades